Stevard LLC’s Novo Nordisk NVO Stock Holding History

Stevard LLC’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,690	Closed	-$302K	–	126
2020 Q3	$302K	Buy	8,690 +1,980	+30%	+$66K	0.13%	106
2020 Q2	$220K	Buy	+6,710	New	+$214K	0.11%	134

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Stevard LLC's NVO Position: Q4 2020 in Review

Stevard LLC sold out of Novo Nordisk (NVO) in Q4 2020, closing a stake of 8,690 shares — an estimated $302K sold.

Stevard LLC first reported a position in NVO in Q2 2020 and held it in 2 quarters. The position peaked at $302K in Q3 2020. 702 funds tracked by Wall St. Rank hold NVO as of Q4 2020.

Stevard LLC reported no remaining Novo Nordisk position as of Q4 2020 after selling out during the quarter.
Stevard LLC sold 8,690 Novo Nordisk shares in Q4 2020, an estimated $302K.
Stevard LLC first reported a position in Novo Nordisk in Q2 2020 and held it in 2 quarters.
Stevard LLC's Novo Nordisk position peaked at $302K in Q3 2020.
702 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2020.

Based on Stevard LLC's 13F filing for Q4 2020, filed 12 Feb 2021.